Commonalities and differences in legal euthanasia and physician-assisted suicide in three countries: a population-level comparison.
Adolescent
Adult
Age Factors
Aged
Aged, 80 and over
Belgium
Cross-Cultural Comparison
Decision Making
Euthanasia
/ legislation & jurisprudence
Female
Humans
Male
Middle Aged
Netherlands
Practice Patterns, Physicians'
/ statistics & numerical data
Suicide, Assisted
/ legislation & jurisprudence
Surveys and Questionnaires
Switzerland
Young Adult
Belgium
End-of-life decision-making
Euthanasia
Physician-assisted suicide
Switzerland
The Netherlands
Journal
International journal of public health
ISSN: 1661-8564
Titre abrégé: Int J Public Health
Pays: Switzerland
ID NLM: 101304551
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
received:
13
04
2019
accepted:
28
06
2019
revised:
12
06
2019
pubmed:
13
7
2019
medline:
4
9
2020
entrez:
13
7
2019
Statut:
ppublish
Résumé
To describe and compare euthanasia and physician-assisted suicide (EAS) practice in Flanders, Belgium (BE), the Netherlands (NL) and Switzerland (CH). Mortality follow-back surveys among attending physicians of a random sample of death certificates. We studied 349 EAS deaths in BE (4.6% of all deaths), 851 in NL (4.6% of all deaths) and 65 in CH (1.4% of all deaths). People who died by EAS were mostly aged 65 or older (BE: 81%, NL: 77% and CH: 71%) and were mostly diagnosed with cancer (BE: 57% and NL: 66%). Home was the most common place of death in NL (79%), while in BE and CH, more variation was found regarding to place of death. The decision to perform EAS was more frequently discussed with a colleague physician in BE (93%) and NL (90%) than in CH (60%). EAS practice characteristics vary considerably in the studied countries with legal EAS. In addition to the legal context, cultural factors as well as the manner in which legislation is implemented play a role in how EAS legislation translates into practice.
Identifiants
pubmed: 31297558
doi: 10.1007/s00038-019-01281-6
pii: 10.1007/s00038-019-01281-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
65-73Subventions
Organisme : Agentschap voor Innovatie door Wetenschap en Technologie
ID : 100036
Organisme : Nederlandse Organisatie voor Wetenschappelijk Onderzoek
ID : 34008003
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
ID : National Research Program 67 "End-of-life"
Références
N Engl J Med. 2017 Aug 3;377(5):492-494
pubmed: 28767342
JAMA. 2014 May 21;311(19):1961-2
pubmed: 24733479
BMC Health Serv Res. 2009 Dec 04;9:220
pubmed: 19961568
N Engl J Med. 2000 Feb 24;342(8):551-6
pubmed: 10684914
BMC Med. 2018 Apr 20;16(1):54
pubmed: 29673342
Swiss Med Wkly. 2016 Mar 02;146:w14307
pubmed: 26934515
Lancet. 2003 Aug 2;362(9381):345-50
pubmed: 12907005
J Am Geriatr Soc. 1997 Oct;45(10):1208-13
pubmed: 9329482
JAMA Intern Med. 2016 Apr;176(4):555-6
pubmed: 26927307
BMC Public Health. 2009 Mar 09;9:79
pubmed: 19272153
N Engl J Med. 2015 Mar 19;372(12):1179-81
pubmed: 25776935
BMC Health Serv Res. 2013 Mar 25;13:116
pubmed: 23530717
Soc Sci Med. 2012 Sep;75(5):845-53
pubmed: 22682367
J Med Ethics. 2015 Aug;41(8):611-7
pubmed: 25142806
Health Policy. 2009 May;90(2-3):181-7
pubmed: 19019485
Int J Epidemiol. 2014 Apr;43(2):614-22
pubmed: 24550250
J Med Ethics. 2008 Nov;34(11):810-4
pubmed: 18974416
J Pain Symptom Manage. 2011 Feb;41(2):436-48
pubmed: 20832983
Br J Cancer. 2015 Nov 3;113(9):1397-404
pubmed: 26325102
Swiss Med Wkly. 2002 Oct 12;132(37-38):527-34
pubmed: 12508137
JAMA. 2016 Jul 5;316(1):79-90
pubmed: 27380345
J Clin Oncol. 2011 Nov 10;29(32):4327-34
pubmed: 21990415
Med Care. 2013 Oct;51(10):938-44
pubmed: 23929402
J Bioeth Inq. 2014 Dec;11(4):507-29
pubmed: 25124983